Health

Collaborative Medicinal Development Enrolls First Patient In a Randomized, Placebo-Controlled Clinical Trial of CuATSM For The Treatment of Amyotrophic Lateral Sclerosis

MILL VALLEY, Calif. and MELBOURNE, Australia, Oct. 15, 2019 /PRNewswire/ -- Collaborative Medicinal Development, LLC) ("CMD"), a clinical stage biopharmaceutical company with a portfolio of candidates for treatment of neurological and neuropsychiatric diseases, announced today that it enrolled t...

2019-10-15 05:58 130

Medisanté Earns Acclaim from Frost & Sullivan for Ensuring Better Care Outcomes while Reducing Costs

With its global medical IoT infrastructure, Medisanté radically simplifies PGHD integration into clinical systems and enables healthcare providers to scale their RPM initiatives SANTA CLARA, California, Oct. 15, 2019 /PRNewswire/ -- Based on its recent analysis of the global remote patient monit...

2019-10-15 04:11 181

WONTECH Receives FDA Clearance for 'HairBoom Air'

SEOUL, South Korea, Oct. 14, 2019 /PRNewswire/ -- WONTECH (Reno Kim, CEO of WONTECH,www.wtlaser.com ) a leading Korean laser and energy based medical aesthetic device company announced that its LLLT hair loss treatment device, HairBoom Air, received U.S. Food and Drug Adm...

2019-10-14 16:47 202

STA To Market Sarcoma Drug In Australia, New Zealand And SE Asia Following License Deal

SINGAPORE and MELBOURNE, Australia, Oct. 14, 2019 /PRNewswire/ -- Independent pharmaceutical company Specialised Therapeutics Asia (STA) has signed a new license deal, enabling it to provide a global advanced sarcoma therapy to patients inAustralia, New Zealand and throughout SE Asia. Under the ...

2019-10-14 14:00 208

Admedus Inks $A36.2M Deal for CardioCel And VascuCel Patch Business

Transaction Highlights: * Admedus has sold the distribution rights to its CardioCel® and VascuCel® product range for$A36.2 million (including all earnouts) to LeMaitre Vascular Inc. * $A22.8M upfront payment plus two instalments of $A1m each after 12 months and 36 months * Up to $A11.4M on...

2019-10-14 12:51 324

The Global Food Safety Initiative (GFSI) Welcomes New Director, Set to Lead Next Chapter of Growth

PARIS, Oct. 14, 2019 /PRNewswire/ -- The Global Food Safety Initiative (GFSI) is excited to welcomeErica Sheward as its new Director. GFSI has been gaining momentum around the world for nearly two decades, and Erica's vast and diverse experience in the food safety industry is expected to help fur...

2019-10-14 09:42 285

ZEISS showcases next-level eye care digitalization at AAO 2019

SAN FRANCISCO, Oct. 12, 2019 /PRNewswire/ -- At the Annual Meeting of the American Academy of Ophthalmology (AAO) inSan Francisco, ZEISS Medical Technology Segment will present the latest in digital eye care innovation and high-resolution imaging fromOctober 12 – 15, 2019. With the vision and the...

2019-10-12 22:00 554

Indonesia's Largest Single-payer System BPJS Kesehatan Teams up with Local Health Apps Startup Halodoc to Improve Equal Access to Health Care Across the Country

JAKARTA, Indonesia, Oct. 11, 2019 /PRNewswire/ -- The Healthcare & Social Security Agency (BPJS Kesehatan), the biggest single-payer system inIndonesia and in the world, officially signed a Memorandum of Understanding with Halodoc, the most innovative online-based integrated health technology app...

2019-10-11 20:35 744

CMAB Biopharma and BJ Bioscience Establish an Exclusive Strategic Partnership

* The new partnership will combine the research and development ingenuity of BJ Bioscience with the state-of-art biologics manufacturing set up of CMAB * CMAB will provide full development and manufacturing services for BJ Bioscience's BJ-005 bi-functional antibody * BJ-005 is planned to ent...

2019-10-11 18:00 1274

Kangpu Biopharmaceuticals Successfully Completed Phase I Study of Novel CRL4-CRBN Modulator KPG-818 in the U.S.

SHANGHAI, Oct. 11, 2019 /PRNewswire/ -- Kangpu Biopharmaceuticals announced today that it has successfully completed a first-in-human phase I single ascending dose (SAD) clinical study of KPG-818 conducted inthe United States. This randomized, double-blind, placebo-controlled study evaluated the...

2019-10-11 13:00 270

Bayer G4A Partners With Wellthy Therapeutics

MUMBAI, India, Oct. 11, 2019 /PRNewswire/ -- Wellthy Therapeutics, South Asia's leading digital therapeutics (DTx) company today announced its partnership with Bayer (BAYN: DE) through its G4A partnership initiative. Wellthy Therapeutics stands out as onefrom over 750 digital health companies spr...

2019-10-11 09:00 673

WuXi AppTec Research Service Division and BioSolveIT Introduce GalaXi®, a Vast New Chemical Space of Tangible Molecules

SHANGHAI and CAMBRIDGE, Massachusetts and SANKT AUGUSTIN, Germany, Oct. 10, 2019 /PRNewswire/ -- WuXi AppTec Research Service Division and BioSolveIT today launched a new virtual chemical space called GalaXi®. Largely built from WuXi AppTec's library of novel drug-like scaffolds, GalaXi® offers a...

2019-10-11 08:02 3539

Caliber Ophthalmics Introduces Sharpoint Edge CC3D Plus Product Line at AAO in San Francisco

WESTWOOD, Massachusetts, Oct. 10, 2019 /PRNewswire/ -- Caliber Ophthalmics, a division of Surgical Specialties Corporation (SSC), announced today the global launch of its Sharpoint™ Edge™ Clear Control 3D Plus line of phaco incision knives at the Annual Meeting of the American Academy of Ophthalm...

2019-10-10 22:09 496

MabPlex Lauded by Frost & Sullivan for Global Expansion of ADC Contract Manufacturing Services

YANTAI, China, Oct. 10, 2019 /PRNewswire/ -- Based on its recent analysis of the global antibody drug conjugate (ADC) contract manufacturing services market, Frost & Sullivan recognizesChina-based MabPlex International, Ltd (MabPlex) with the 2019 Global Growth Excellence Leadership Award. MabPle...

2019-10-10 21:00 409

111 Unveils New Video on What the Internet Could Do for the Health Management of Aging

SHANGHAI, Oct. 10, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, announced the release of the third episode in its 111 Insight series. The title announced today,What the Internet Could Do for the Health Managemen...

2019-10-10 20:31 3546

Saudi Ministry of Health Provides More Accessible Health Services Through Its "937 Call Center"

RIYADH, Saudi Arabia, Oct. 10, 2019 /PRNewswire/ -- In line with the Saudi Vision 2030, the Ministry of Health (MOH) is undergoing a major transformation process to improve access, efficiency, and quality of care and to that end; several initiatives are currently under way. One of the key transfo...

2019-10-10 18:30 411

Innovent and Chi-Med Expand Global Collaboration to Evaluate the Combination of Sintilimab and Surufatinib in Solid Tumors

SUZHOU, China and LONDON, Oct. 10, 2019 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801) and Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) today announced the expansion of their global collaboration agreement to evaluate the safety and efficacy of Innovent's Ty...

2019-10-10 15:55 452

South Korean minister dismisses 5G health, environment concerns

BEIJING, Oct. 10, 2019 /PRNewswire/ -- A news report by China.org.cn: Concerns about possible health and environmental effects caused by 5G networks are "completely groundless," said a senior South Korean government official onOct. 2. Ki-young Choi, the newly appointed minister for science and ...

2019-10-10 14:53 292

Path-breaking Study Reports High Sensitivity in Diabetic Retinopathy Screening Using Smartphones and Automated-AI in Primary-Care: Remidio Innovative Solutions

BENGALURU, India, Oct. 10, 2019 /PRNewswire/ -- Nearly 50% of patients with diabetes fail to get an annual eye examination done even in the US and EU. In many countries, less than 10% of patients referred to ophthalmologists by their primary-care physicians actually complete a dilated retinal exa...

2019-10-10 11:34 549

Volition Appoints Dr. Phillip Barnes to Board of Directors

AUSTIN, Texas, Oct. 9, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced the appointment of Dr.Phillip Barnes to the Company's Board of Directors as a Non-Executive Director, effectiveOctober 9, 2019. Dr. Barnes was also appointed to the Company's Audit, C...

2019-10-10 04:05 4000
12345 ... 761